{
  "target_name": "HER2",
  "paper_count": 65,
  "paper_count_year": {
    "2000": [1, 2, 10],
    "2001": [3, 7, 17],
    "2002": [8, 12, 21],
    "2003": [8, 17, 30],
    "2004": [15, 20, 31],
    "2005": [11, 11, 26],
    "2006": [13, 36, 36],
    "2007": [10, 17, 24],
    "2008": [12, 25, 21],
    "2009": [11, 34, 35],
    "2010": [17, 30, 69],
    "2011": [17, 41, 61],
    "2012": [24, 31, 81],
    "2013": [21, 37, 88],
    "2014": [41, 33, 87],
    "2015": [34, 23, 84],
    "2016": [41, 27, 93],
    "2017": [52, 39, 98],
    "2018": [66, 38, 81],
    "2019": [71, 36, 99],
    "2020": [77, 45, 89],
    "2021": [65, 55, 63],
    "1953": [0, 1, 2],
    "1974": [0, 1, 0],
    "1983": [0, 1, 0],
    "1992": [0, 1, 2],
    "1996": [0, 2, 3],
    "1997": [0, 4, 2],
    "1998": [0, 4, 5],
    "1999": [0, 6, 7],
    "1831": [0, 0, 1],
    "1837": [0, 0, 1],
    "1854": [0, 0, 1],
    "1867": [0, 0, 1],
    "1884": [0, 0, 2],
    "1903": [0, 0, 1],
    "1905": [0, 0, 1],
    "1923": [0, 0, 1],
    "1928": [0, 0, 1],
    "1937": [0, 0, 1],
    "1939": [0, 0, 1],
    "1948": [0, 0, 1],
    "1949": [0, 0, 1],
    "1950": [0, 0, 1],
    "1954": [0, 0, 2],
    "1955": [0, 0, 1],
    "1956": [0, 0, 3],
    "1957": [0, 0, 3],
    "1958": [0, 0, 2],
    "1959": [0, 0, 3],
    "1960": [0, 0, 3],
    "1961": [0, 0, 5],
    "1962": [0, 0, 2],
    "1963": [0, 0, 6],
    "1964": [0, 0, 4],
    "1965": [0, 0, 4],
    "1966": [0, 0, 4],
    "1967": [0, 0, 4],
    "1968": [0, 0, 4],
    "1969": [0, 0, 3],
    "1970": [0, 0, 3],
    "1972": [0, 0, 1],
    "1973": [0, 0, 3],
    "1987": [0, 0, 2],
    "1988": [0, 0, 2],
    "1989": [0, 0, 4],
    "1990": [0, 0, 1],
    "1993": [0, 0, 3],
    "1994": [0, 0, 1],
    "1995": [0, 0, 2]
  },
  "drug_molecule_count": 27,
  "drug_molecule_paper": [
    {
      "id": 0,
      "paper_title": "HER2 Kinase-Targeted Breast Cancer Therapy: Design, Synthesis, and In Vitro and In Vivo Evaluation of Novel Lapatinib Congeners as Selective and Potent HER2 Inhibitors with Favorable Metabolic Stability",
      "paper_author": [
        "Tamer A. Elwaie",
        "Safinaz E. Abbas",
        "Enayat I. Aly",
        "Riham F. George",
        "Hamdy Ali",
        "Nikolai Kraiouchkine",
        "Khaldoun S. Abdelwahed",
        "Tamer E. Fandy",
        "Khalid A. El Sayed",
        "Zakaria Y. Abd Elmageed",
        "Hamed I. Ali"
      ],
      "paper_year": 2020,
      "paper_institution": "",
      "paper_cited": 2,
      "doi": "10.1021/acs.jmedchem.0c01647",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01647/20201218/images/large/jm0c01647_0025.jpeg",
      "compound_count": 103,
      "compound_name": "17d",
      "compound_name_drug": "",
      "compound_smiles": "N1(CCN(CCCOC)CC1)C",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 12.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 205.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 2.42,
        "bioavailability": 100.2
      },
      "clinical_statistics": {}
    },
    {
      "id": 1,
      "paper_title": "Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-d]pyrimidine Scaffold",
      "paper_author": [
        "Tomoyasu Ishikawa",
        "Masaki Seto",
        "Hiroshi Banno",
        "Youichi Kawakita",
        "Mami Oorui",
        "Takahiko Taniguchi",
        "Yoshikazu Ohta",
        "Toshiya Tamura",
        "Akiko Nakayama",
        "Hiroshi Miki",
        "Hidenori Kamiguchi",
        "Toshimasa Tanaka",
        "Noriyuki Habuka",
        "Satoshi Sogabe",
        "Jason Yano",
        "Kathleen Aertgeerts",
        "Keiji Kamiyama"
      ],
      "paper_year": 2011,
      "paper_institution": "Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan",
      "paper_cited": 99,
      "doi": "10.1021/jm2008634",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-23/jm2008634/production/images/large/jm-2011-008634_0015.jpeg",
      "compound_count": 100,
      "compound_name": "34e",
      "compound_name_drug": "TAK-285",
      "compound_smiles": "CC(C)(CC(=O)NCCN1C=CC2=C1C(=NC=N2)NC3=CC(=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F)Cl)O",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 17.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 5.63,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {
        "p1_company_num": 1,
        "p1_stat_company_num": [0, 0, 0, 0, 0, 0, 1, 0, 0],
        "p1_company": [
          [],
          [],
          [],
          [],
          [],
          [],
          ["Millennium Pharmaceuticals, Inc."],
          [],
          []
        ],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 0,
        "p2_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p2_company": [[], [], [], [], [], [], [], [], []],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": {},
        "p3_company_num": 0,
        "p3_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p3_company": [[], [], [], [], [], [], [], [], []],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 2,
      "paper_title": "Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer",
      "paper_author": ["John M. Lambert", "Ravi V. J. Chari"],
      "paper_year": 2014,
      "paper_institution": "ImmunoGen, Inc., 830 Winter Street, Waltham, Massachusetts 02451, United States",
      "paper_cited": 263,
      "doi": "10.1021/jm500766w",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-16/jm500766w/production/images/large/jm-2014-00766w_0011.jpeg",
      "compound_count": 2,
      "compound_name": "1",
      "compound_name_drug": "T-DM1",
      "compound_smiles": "[*]NC(=O)[C@@H]1CC[C@@H](CN2C(=O)CC(SCCC(=O)N(C)[C@@H](C)C(=O)O[C@H]3CC(=O)N(C)c4cc(C\\C(=C\\C=C\\[C@@H](OC)[C@@]5(O)C[C@H](OC(=O)N5)[C@@H](C)[C@@H]6O[C@@]36C)\\C)cc(OC)c4Cl)C2=O)CC1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.16,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 11.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 72.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {
        "p1_company_num": 56,
        "p1_stat_company_num": [0, 2, 0, 3, 0, 1, 50, 0, 0],
        "p1_company": [
          [],
          ["UCLA Hematology/Oncology Parkside", "OHSU Knight Cancer Institute"],
          [],
          [
            "Internal Medicine Hematology Oncology",
            "Stanford Cancer Institute",
            "Dana Farber Cancer Insitute"
          ],
          [],
          ["Cancer Trials Ireland"],
          [
            "The Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU)",
            "The Methodist Hospital Research Institute",
            "University of Miami",
            "H. Lee Moffitt Cancer Center and Research Institute",
            "The University of Arizona Cancer Center",
            "Houston Methodist Cancer Center",
            "Breast Center of the University of Munich (LMU), Universitätsfrauenklinik Großhadern, Munich, Germany",
            "Seagen Inc.",
            "Grande Ospedale Metropolitano Niguarda - Milano",
            "Hoffmann-La Roche",
            "Jules Bordet Institute",
            "Northwestern University",
            "Western Regional Medical Center",
            "Sun Yat-sen University",
            "National Cancer Institute (NCI)",
            "Merck Sharp & Dohme Corp.",
            "NSABP Foundation Inc",
            "Arnau de Vilanova Hospital, Valencia (Spain)",
            "Mayo Clinic",
            "Korea University Guro Hospital",
            "Aichi Cancer Center Hospital",
            "Children's Oncology Group",
            "NKI-AvL",
            "Hospital Clinic of Barcelona",
            "Karolinska University Hospital",
            "ECOG-ACRIN Cancer Research Group",
            "Genentech, Inc.",
            "Fondazione per la Medicina Personalizzata",
            "Memorial Sloan Kettering Cancer Center",
            "Ruijin Hospital",
            "UZ Leuven, Leuven, Belgium",
            "Ambrx, Inc.",
            "University of Rochester",
            "University of Washington Medicine Seattle",
            "SOLTI Breast Cancer Research Group",
            "KUCC",
            "US Oncology Research, McKesson Specialty Health",
            "Kanagawa Cancer Center",
            "Daiichi Sankyo, Inc.",
            "ICM Co. Ltd.",
            "University of Ulm",
            "Breast-sarcoma unit, Dept. of Oncology, Karolinska university hospital",
            "Washington Cancer Institute at MedStar Washington Hospital Center",
            "Academic and Community Cancer Research United",
            "UCL",
            "Hospital Ramon y Cajal, Madrid, Spain",
            "University of California, San Francisco",
            "US Oncology Research/McKesson Specialty Health",
            "Fred Hutch/University of Washington Cancer Consortium",
            "Dana-Farber Cancer Institute"
          ],
          [],
          []
        ],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 46,
        "p2_stat_company_num": [3, 18, 0, 6, 1, 2, 13, 1, 2],
        "p2_company": [
          [
            "Jules Bordet Institute",
            "University of Rochester",
            "Arnau de Vilanova Hospital, Valencia (Spain)"
          ],
          [
            "The Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU)",
            "National Cancer Institute (NCI)",
            "Merck Sharp & Dohme Corp.",
            "The University of Arizona Cancer Center",
            "NKI-AvL",
            "Hospital Clinic of Barcelona",
            "ECOG-ACRIN Cancer Research Group",
            "Fondazione per la Medicina Personalizzata",
            "Memorial Sloan Kettering Cancer Center",
            "Ruijin Hospital",
            "Ambrx, Inc.",
            "University of Washington Medicine Seattle",
            "SOLTI Breast Cancer Research Group",
            "Academic and Community Cancer Research United",
            "UCL",
            "University of California, San Francisco",
            "US Oncology Research/McKesson Specialty Health",
            "Dana-Farber Cancer Institute"
          ],
          [],
          [
            "NSABP Foundation Inc",
            "KUCC",
            "US Oncology Research, McKesson Specialty Health",
            "Korea University Guro Hospital",
            "Children's Oncology Group",
            "UZ Leuven, Leuven, Belgium"
          ],
          ["Karolinska University Hospital"],
          ["University of Miami", "Western Regional Medical Center"],
          [
            "The Methodist Hospital Research Institute",
            "Kanagawa Cancer Center",
            "Daiichi Sankyo, Inc.",
            "Mayo Clinic",
            "University of Ulm",
            "H. Lee Moffitt Cancer Center and Research Institute",
            "Breast-sarcoma unit, Dept. of Oncology, Karolinska university hospital",
            "Washington Cancer Institute at MedStar Washington Hospital Center",
            "Aichi Cancer Center Hospital",
            "Hoffmann-La Roche",
            "Genentech, Inc.",
            "Sun Yat-sen University",
            "Seagen Inc."
          ],
          ["Houston Methodist Cancer Center"],
          [
            "Breast Center of the University of Munich (LMU), Universitätsfrauenklinik Großhadern, Munich, Germany",
            "Grande Ospedale Metropolitano Niguarda - Milano"
          ]
        ],
        "p2_terminate_reason": {
          "University of Miami": "Withdrawal by Subject",
          "Hoffmann-La Roche": "Withdrawal by Subject"
        },
        "p2_withdraw_reason": {},
        "p2_adverse_event": {
          "Hoffmann-La Roche": 0.10135135135135136,
          "Genentech, Inc.": 0.0784313725490196,
          "University of Miami": 1.0,
          "Washington Cancer Institute at MedStar Washington Hospital Center": 0.1,
          "H. Lee Moffitt Cancer Center and Research Institute": 0.4666666666666667
        },
        "p3_company_num": 9,
        "p3_stat_company_num": [0, 5, 0, 3, 0, 0, 1, 0, 0],
        "p3_company": [
          [],
          [
            "Kanagawa Cancer Center",
            "Daiichi Sankyo, Inc.",
            "Mayo Clinic",
            "Hoffmann-La Roche",
            "Seagen Inc."
          ],
          [],
          [
            "Breast-sarcoma unit, Dept. of Oncology, Karolinska university hospital",
            "Aichi Cancer Center Hospital",
            "Sun Yat-sen University"
          ],
          [],
          [],
          ["Genentech, Inc."],
          [],
          []
        ],
        "p3_terminate_reason": { "Hoffmann-La Roche": "Death" },
        "p3_withdraw_reason": {},
        "p3_adverse_event": { "Hoffmann-La Roche": 0.2531017369727047 }
      }
    },
    {
      "id": 3,
      "paper_title": "Design and Synthesis of Pyrrolo[3,2-d]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket Binders",
      "paper_author": [
        "Youichi Kawakita",
        "Hiroshi Banno",
        "Tomohiro Ohashi",
        "Toshiya Tamura",
        "Tadashi Yusa",
        "Akiko Nakayama",
        "Hiroshi Miki",
        "Hidehisa Iwata",
        "Hidenori Kamiguchi",
        "Toshimasa Tanaka",
        "Noriyuki Habuka",
        "Satoshi Sogabe",
        "Yoshikazu Ohta",
        "Tomoyasu Ishikawa"
      ],
      "paper_year": 2012,
      "paper_institution": "Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited: 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan",
      "paper_cited": 28,
      "doi": "10.1021/jm300185p",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm300185p/production/images/large/jm-2012-00185p_0001.jpeg",
      "compound_count": 98,
      "compound_name": "51m",
      "compound_name_drug": "",
      "compound_smiles": "n1(ccc2c1c(Nc1ccc(Oc3cccc(c3)C(=O)O)c(Cl)c1)ncn2)CCO",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.98,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.9,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 4,
      "paper_title": "Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future Perspectives",
      "paper_author": [
        "Stefania De Luca",
        "Valentina Verdoliva",
        "Michele Saviano"
      ],
      "paper_year": 2020,
      "paper_institution": "",
      "paper_cited": -1,
      "doi": "10.1021/acs.jmedchem.0c01340",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-24/acs.jmedchem.0c01340/20201218/images/large/jm0c01340_0016.jpeg",
      "compound_count": 0,
      "compound_name": "88900",
      "compound_name_drug": "",
      "compound_smiles": "c12ccccc2[nH]cc1CC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CN(CCN(CC(=O)O)CCN(CC(=O)O)CC(=O)C)CC(=O)O)CCC(=O)N)CC(=O)O)C(C)C)CC(=O)N)C)C(C)C)C)C(=O)N",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 4.9,
        "IC50": 0.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 5,
      "paper_title": "Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer",
      "paper_author": [
        "Xiong Cai",
        "Hai-Xiao Zhai",
        "Jing Wang",
        "Jeffrey Forrester",
        "Hui Qu",
        "Ling Yin",
        "Cheng-Jung Lai",
        "Rudi Bao",
        "Changgeng Qian"
      ],
      "paper_year": 2010,
      "paper_institution": "Curis Inc., 45 Moulton Street, Cambridge, Massachusetts 02138",
      "paper_cited": 164,
      "doi": "10.1021/jm901453q",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901453q/production/images/large/jm-2009-01453q_0015.jpeg",
      "compound_count": 74,
      "compound_name": "8",
      "compound_name_drug": "CUDC-101",
      "compound_smiles": "COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 15.7,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 600.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {
        "p1_company_num": 1,
        "p1_stat_company_num": [0, 0, 0, 0, 0, 0, 1, 0, 0],
        "p1_company": [
          [],
          [],
          [],
          [],
          [],
          [],
          ["START (South Texas Accelerated Research Therapeutics)"],
          [],
          []
        ],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 0,
        "p2_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p2_company": [[], [], [], [], [], [], [], [], []],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": {},
        "p3_company_num": 0,
        "p3_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p3_company": [[], [], [], [], [], [], [], [], []],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 6,
      "paper_title": "Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity",
      "paper_author": [
        "Siavosh Mahboobi",
        "Andreas Sellmer",
        "Matthias Winkler",
        "Emerich Eichhorn",
        "Herwig Pongratz",
        "Thomas Ciossek",
        "Thomas Baer",
        "Thomas Maier",
        "Thomas Beckers"
      ],
      "paper_year": 2010,
      "paper_institution": "Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany",
      "paper_cited": 65,
      "doi": "10.1021/jm100665z",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-24/jm100665z/production/images/large/jm-2010-00665z_0006.jpeg",
      "compound_count": 43,
      "compound_name": "5",
      "compound_name_drug": "",
      "compound_smiles": "N(c1ccccc1)[S](=O)(C([I]C)c1cccc(/C=C/C(=O)NO)c1)CC",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 4.1,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 32.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 7,
      "paper_title": "Discovery of Novel Small-Molecule Inhibitors of Human Epidermal Growth Factor Receptor-2: Combined Ligand and Target-Based Approach",
      "paper_author": [
        "Rambabu Gundla",
        "Roza Kazemi",
        "Ramadevi Sanam",
        "Ravikumar Muttineni",
        "Jagarlapudi A. R. P. Sarma",
        "Raveendra Dayam",
        "Nouri Neamati"
      ],
      "paper_year": 2008,
      "paper_institution": "Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, California, Division of Informatics, GVK Biosciences Pvt. Ltd., Technocrats Industrial Estate, Balanagar, Hyderabad, Andhra Pradesh, India",
      "paper_cited": 93,
      "doi": "10.1021/jm7013875",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-12/jm7013875/production/images/large/jm-2007-013875_0012.jpeg",
      "compound_count": 23,
      "compound_name": "3",
      "compound_name_drug": "",
      "compound_smiles": "C(Oc1c(NC(=O)/C=C/CN(C)C)cc2c(Nc3ccc(OCc4cccc(Cl)c4)c(Cl)c3)c(C#N)cnc2c1)C",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 9.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 2000.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 8,
      "paper_title": "Structure−Activity Relationships of Small Phosphopeptides, Inhibitors of Grb2 SH2 Domain, and Their Prodrugs",
      "paper_author": [
        "Wang-Qing Liu",
        "Michel Vidal",
        "Catherine Olszowy",
        "Emmanuelle Million",
        "Christine Lenoir",
        "Hélène Dhôtel",
        "Christiane Garbay"
      ],
      "paper_year": 2004,
      "paper_institution": "Département de Pharmacochimie Moléculaire & Structurale, INSERM U266, CNRS FRE 2463, UFR des Sciences Pharmaceutiques et Biologiques, 4, Avenue de l'Observatoire, 75270 Paris Cedex 06, France ",
      "paper_cited": 26,
      "doi": "10.1021/jm031005k",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2004/jmcmar.2004.47.issue-5/jm031005k/production/images/large/jm031005kn00001.jpeg",
      "compound_count": 122,
      "compound_name": "2",
      "compound_name_drug": "",
      "compound_smiles": "c1c(C)cc(CC)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 4.5,
        "IC50": 14.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 200.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 100.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 9,
      "paper_title": "Discovery and Preclinical Evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid, (3S)-3-Morpholinylmethyl Ester (BMS-599626), a Selective and Orally Efficacious Inhibitor of Human Epidermal Growth Factor Receptor 1 and 2 Kinases",
      "paper_author": [
        "Ashvinikumar V. Gavai",
        "Brian E. Fink",
        "David J. Fairfax",
        "Gregory S. Martin",
        "Lana M. Rossiter",
        "Christian L. Holst",
        "Soong-Hoon Kim",
        "Kenneth J. Leavitt",
        "Harold Mastalerz",
        "Wen-Ching Han",
        "Derek Norris",
        "Bindu Goyal",
        "Shankar Swaminathan",
        "Bharat Patel",
        "Arvind Mathur",
        "Dolatrai M. Vyas",
        "John S. Tokarski",
        "Chiang Yu",
        "Simone Oppenheimer",
        "Hongjian Zhang",
        "Punit Marathe",
        "Joseph Fargnoli",
        "Francis Y. Lee",
        "Tai W. Wong",
        "Gregory D. Vite"
      ],
      "paper_year": 2009,
      "paper_institution": "Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543",
      "paper_cited": 19,
      "doi": "10.1021/jm9010065",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-21/jm9010065/production/images/large/jm-2009-010065_0003.jpeg",
      "compound_count": 1,
      "compound_name": "13",
      "compound_name_drug": "",
      "compound_smiles": "CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 32.0,
        "selectivity": 100
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 310.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 147.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 83.0
      },
      "clinical_statistics": {
        "p1_company_num": 4,
        "p1_stat_company_num": [0, 0, 0, 0, 0, 0, 3, 1, 0],
        "p1_company": [
          [],
          [],
          [],
          [],
          [],
          [],
          [
            "Duke Health",
            "Jonsson Comprehensive Cancer Center",
            "Bristol-Myers Squibb"
          ],
          ["Interim Chief Medical Officer / Ambit Biosciences Corporation"],
          []
        ],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 0,
        "p2_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p2_company": [[], [], [], [], [], [], [], [], []],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": {},
        "p3_company_num": 0,
        "p3_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p3_company": [[], [], [], [], [], [], [], [], []],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 10,
      "paper_title": "Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer",
      "paper_author": [
        "Shu-Yu Lin",
        "Yung Chang Hsu",
        "Yi-Hui Peng",
        "Yi-Yu Ke",
        "Wen-Hsing Lin",
        "Hsu-Yi Sun",
        "Hui-Yi Shiao",
        "Fu-Ming Kuo",
        "Pei-Yi Chen",
        "Tzu-Wen Lien",
        "Chun-Hwa Chen",
        "Chang-Ying Chu",
        "Sing-Yi Wang",
        "Kai-Chia Yeh",
        "Ching-Ping Chen",
        "Tsu-An Hsu",
        "Su-Ying Wu",
        "Teng-Kuang Yeh",
        "Chiung-Tong Chen",
        "Hsing-Pang Hsieh"
      ],
      "paper_year": 2019,
      "paper_institution": "",
      "paper_cited": 5,
      "doi": "10.1021/acs.jmedchem.9b00722",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b00722/20191122/images/large/jm9b00722_0015.jpeg",
      "compound_count": 67,
      "compound_name": "2",
      "compound_name_drug": "DBPR112",
      "compound_smiles": "O=C(NC1=CC=CC(C2=C(C3=CC=CC=C3)OC4=NC=NC(N[C@@H](C5=CC=CC=C5)CO)=C42)=C1)/C=C/CN(C)C",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 48.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.203,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 1520.0,
        "solubility": 0.0,
        "t_half": 2.3,
        "bioavailability": 41.5
      },
      "clinical_statistics": {
        "p1_company_num": 0,
        "p1_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p1_company": [[], [], [], [], [], [], [], [], []],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 0,
        "p2_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p2_company": [[], [], [], [], [], [], [], [], []],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": {},
        "p3_company_num": 0,
        "p3_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p3_company": [[], [], [], [], [], [], [], [], []],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 11,
      "paper_title": "New Novobiocin Analogues as Antiproliferative Agents in Breast Cancer Cells and Potential Inhibitors of Heat Shock Protein 90",
      "paper_author": [
        "Gaëlle Le Bras",
        "Christine Radanyi",
        "Jean-François Peyrat",
        "Jean-Daniel Brion",
        "Mouâd Alami",
        "Véronique Marsaud",
        "Barbara Stella",
        "Jack-Michel Renoir"
      ],
      "paper_year": 2007,
      "paper_institution": "University of Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, and University of Paris-Sud, CNRS, UMR 8612, Laboratoire de Pharmacologie Cellulaire et Moléculaire des Anticancéreux, Faculté de Pharmacie, IFR 141, 5 rue J.-B. Clément, Châtenay-Malabry, F-92296, France ",
      "paper_cited": 105,
      "doi": "10.1021/jm0707774",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-24/jm0707774/production/images/large/jm0707774n00001.jpeg",
      "compound_count": 104,
      "compound_name": "6f",
      "compound_name_drug": "",
      "compound_smiles": "O(c1ccc2c(O)c(NC(=O)c3ccc4OC(CCc4c3)(C)C)c(=O)oc2c1C)S(=O)(=O)c1ccc(C)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 75000.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 12,
      "paper_title": "Design and Evaluation of Potent EGFR Inhibitors through the Incorporation of Macrocyclic Polyamine Moieties into the 4-Anilinoquinazoline Scaffold",
      "paper_author": [
        "Yilan Ju",
        "Jintao Wu",
        "Xi Yuan",
        "Luqing Zhao",
        "Ganlin Zhang",
        "Chao Li",
        "Renzhong Qiao"
      ],
      "paper_year": 2018,
      "paper_institution": "",
      "paper_cited": 12,
      "doi": "10.1021/acs.jmedchem.8b01612",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b01612/20181226/images/large/jm-2018-01612b_0008.jpeg",
      "compound_count": 38,
      "compound_name": "1f",
      "compound_name_drug": "",
      "compound_smiles": "c1c(c(c(cc1C(=O)O[C@@H]1Cc2c(cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)O)O)O)O",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 2.1,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 958.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 13,
      "paper_title": "Identification and Characterization of a Novel Integrin-Linked Kinase Inhibitor",
      "paper_author": [
        "Su-Lin Lee",
        "En-Chi Hsu",
        "Chih-Chien Chou",
        "Hsiao-Ching Chuang",
        "Li-Yuan Bai",
        "Samuel K. Kulp",
        "Ching-Shih Chen"
      ],
      "paper_year": 2011,
      "paper_institution": "Division of Medicinal Chemistry, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, 336 Parks Hall, 500 West 12th Avenue, Columbus, OH 43210, United States",
      "paper_cited": 52,
      "doi": "10.1021/jm2007744",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm2007744/production/images/large/jm-2011-007744_0010.jpeg",
      "compound_count": 11,
      "compound_name": "22",
      "compound_name_drug": "",
      "compound_smiles": "C(N(CC)c1ccc(n2nc(CCC(=O)NC)cc2c2ccc(c3ccc(C(F)(F)F)cc3)cc2)cc1)CN",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 600.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 250.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 14,
      "paper_title": "Structure–Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells",
      "paper_author": [
        "Andrew J. Robles",
        "Shelby McCowen",
        "Shengxin Cai",
        "Michaels Glassman",
        "Francisco Ruiz, II",
        "Robert H. Cichewicz",
        "Stanton F. McHardy",
        "Susan L. Mooberry"
      ],
      "paper_year": 2017,
      "paper_institution": "Department of Pharmacology and ‡UT Health San Antonio Cancer Center, UT Health San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229, United States",
      "paper_cited": 18,
      "doi": "10.1021/acs.jmedchem.7b01228",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b01228/20171117/images/large/jm-2017-01228d_0009.jpeg",
      "compound_count": 32,
      "compound_name": "30",
      "compound_name_drug": "",
      "compound_smiles": "C(C)(CCC/C(=C/COc1ccc(c2cnc(o2)c2cnccc2)cc1)/C)C",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 800.0,
        "selectivity": 38
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 15,
      "paper_title": "pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure–activity relationship and biological activity as potential antitumor and anticonvulsant agents",
      "paper_author": [
        "Phoebe F. Lamie",
        "Asmaa M. El-Kalaawy",
        "Noha S. Abdel Latif",
        "Laila A. Rashed",
        "John N. Philoppes"
      ],
      "paper_year": 2021,
      "paper_institution": "Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt",
      "paper_cited": 0,
      "doi": "10.1016/j.ejmech.2021.113222",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421000714-fx1_lrg.jpg",
      "compound_count": 49,
      "compound_name": "6o",
      "compound_name_drug": "",
      "compound_smiles": "c1(n2c(c(c(n2)C)C#N)N)ccccc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 422.3,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 4.8,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 16,
      "paper_title": "Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)",
      "paper_author": [
        "Zhuyu Xu",
        "Dandan Guo",
        "Zhongliang Jiang",
        "Rongsheng Tong",
        "Peidu Jiang",
        "Lan Bai",
        "Lu Chen",
        "Yuxuan Zhu",
        "Chun Guo",
        "Jianyou Shi",
        "Dongke Yu"
      ],
      "paper_year": 2019,
      "paper_institution": "Department of Pharmacy, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, Personalized Drug Therapy Key Laboratory of Sichuan Province, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China",
      "paper_cited": 20,
      "doi": "10.1016/j.ejmech.2019.111682",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419308323-fx1_lrg.jpg",
      "compound_count": 0,
      "compound_name": "74",
      "compound_name_drug": "",
      "compound_smiles": "CC[C@@]1(O)C(OCC2=C1C=C3N(C2=O)CC(C3=NC4=CC(F)=C5C)=C6C4=C5CC[C@@H]6NC(COCNC(CNC([C@@H](NC(CNC(CNC(CCCCCN7C(C=CC7=O)=O)=O)=O)=O)CC8=CC=CC=C8)=O)=O)=O)=O",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 7.8,
        "IC50": 0.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 3.8,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {
        "p1_company_num": 14,
        "p1_stat_company_num": [0, 3, 0, 0, 0, 0, 11, 0, 0],
        "p1_company": [
          [],
          [
            "National Cancer Institute LAO",
            "Dana-Farber - Harvard Cancer Center LAO",
            "University of Texas MD Anderson Cancer Center LAO"
          ],
          [],
          [],
          [],
          [],
          [
            "Centre Eugène Marquis",
            "Hoffmann-La Roche",
            "Pediatric Early Phase Clinical Trial Network",
            "Seagen Inc.",
            "Dana-Farber Cancer Institute",
            "MedSIR",
            "Barts Cancer Institute",
            "Daiichi Sankyo, Inc.",
            "UCLA / Jonsson Comprehensive Cancer Center",
            "Medical University of Vienna",
            "The University of Texas MD Anderson Cancer Center"
          ],
          [],
          []
        ],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 11,
        "p2_stat_company_num": [1, 7, 0, 1, 0, 1, 1, 0, 0],
        "p2_company": [
          ["Dana-Farber Cancer Institute"],
          [
            "Pediatric Early Phase Clinical Trial Network",
            "Seagen Inc.",
            "MedSIR",
            "Barts Cancer Institute",
            "UCLA / Jonsson Comprehensive Cancer Center",
            "Medical University of Vienna",
            "The University of Texas MD Anderson Cancer Center"
          ],
          [],
          ["Centre Eugène Marquis"],
          [],
          ["Hoffmann-La Roche"],
          ["Daiichi Sankyo, Inc."],
          [],
          []
        ],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": { "Daiichi Sankyo, Inc.": 0.44 },
        "p3_company_num": 1,
        "p3_stat_company_num": [0, 1, 0, 0, 0, 0, 0, 0, 0],
        "p3_company": [
          [],
          ["Daiichi Sankyo, Inc."],
          [],
          [],
          [],
          [],
          [],
          [],
          []
        ],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 17,
      "paper_title": "Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors",
      "paper_author": [
        "Sandra N. Milik",
        "Amal Kamal Abdel-Aziz",
        "Deena S. Lasheen",
        "Rabah A.T. Serya",
        "Saverio Minucci",
        "Khaled A.M. Abouzid"
      ],
      "paper_year": 2018,
      "paper_institution": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, 11566, Egypt",
      "paper_cited": 23,
      "doi": "10.1016/j.ejmech.2018.06.011",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418305026-fx1_lrg.jpg",
      "compound_count": 60,
      "compound_name": "27b",
      "compound_name_drug": "",
      "compound_smiles": "N(c1ccc(c2cc3c(Nc4ccc(Oc5cccc(c5)C(F)(F)F)c(Cl)c4)ncnc3s2)cc1)C(=O)/C=C/C(C)C",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 91.7,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 4830.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 18,
      "paper_title": "Discovery of anilino-furo[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activity",
      "paper_author": [
        "Monia Hossam",
        "Deena S. Lasheen",
        "Nasser S.M. Ismail",
        "Ahmed Esmat",
        "Ahmed M. Mansour",
        "Abdel Nasser B. Singab",
        "Khaled A.M. Abouzid"
      ],
      "paper_year": 2018,
      "paper_institution": "Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt",
      "paper_cited": 14,
      "doi": "10.1016/j.ejmech.2017.12.022",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417310280-fx1_lrg.jpg",
      "compound_count": 73,
      "compound_name": "8d",
      "compound_name_drug": "",
      "compound_smiles": "c12oc(c(c1c(Nc1ccc(OCc3cc(F)ccc3)c(Cl)c1)ncn2)C(=O)O)C",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 752.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 68000.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 19,
      "paper_title": "Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors",
      "paper_author": [
        "Mansour S. Alsaid",
        "Abdullah A. Al-Mishari",
        "Aiten M. Soliman",
        "Fatma A. Ragab",
        "Mostafa M. Ghorab"
      ],
      "paper_year": 2017,
      "paper_institution": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia",
      "paper_cited": 13,
      "doi": "10.1016/j.ejmech.2017.09.061",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417307766-fx1_lrg.jpg",
      "compound_count": 34,
      "compound_name": "18",
      "compound_name_drug": "",
      "compound_smiles": "c1cccc2c1cc1c(=O)n(c(nc1c2)S)c1ccc(S(=O)(=O)N)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 390.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 120.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 20,
      "paper_title": "Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors",
      "paper_author": [
        "Mansour S. Alsaid",
        "Abdullah A. Al-Mishari",
        "Aiten M. Soliman",
        "Fatma A. Ragab",
        "Mostafa M. Ghorab"
      ],
      "paper_year": 2017,
      "paper_institution": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia",
      "paper_cited": 13,
      "doi": "10.1016/j.ejmech.2017.09.061",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417307766-fx1_lrg.jpg",
      "compound_count": 34,
      "compound_name": "18",
      "compound_name_drug": "",
      "compound_smiles": "c1cccc2c1cc1c(=O)n(c(nc1c2)S)c1ccc(S(=O)(=O)N)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 390.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 120.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 21,
      "paper_title": "Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors",
      "paper_author": [
        "Mansour S. Alsaid",
        "Abdullah A. Al-Mishari",
        "Aiten M. Soliman",
        "Fatma A. Ragab",
        "Mostafa M. Ghorab"
      ],
      "paper_year": 2017,
      "paper_institution": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia",
      "paper_cited": 13,
      "doi": "10.1016/j.ejmech.2017.09.061",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417307766-fx1_lrg.jpg",
      "compound_count": 34,
      "compound_name": "18",
      "compound_name_drug": "",
      "compound_smiles": "c1cccc2c1cc1c(=O)n(c(nc1c2)S)c1ccc(S(=O)(=O)N)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 390.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 120.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 22,
      "paper_title": "A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models",
      "paper_author": [
        "Sitanshu S. Singh",
        "George Mattheolabakis",
        "Xin Gu",
        "Sita Withers",
        "Achyut Dahal",
        "Seetharama Jois"
      ],
      "paper_year": 2021,
      "paper_institution": "School of Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, 71201, USA",
      "paper_cited": 1,
      "doi": "10.1016/j.ejmech.2021.113312",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421001616-fx1_lrg.jpg",
      "compound_count": 1,
      "compound_name": ".",
      "compound_name_drug": "",
      "compound_smiles": "CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)C(NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N2)[C@@H](C)O)C(C)CC",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 73.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 4220.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 23,
      "paper_title": "Design, synthesis and biological evaluation of quinazoline–phosphoramidate mustard conjugates as anticancer drugs",
      "paper_author": [
        "Songwen Lin",
        "Yingbo Li",
        "Yufen Zheng",
        "Laichun Luo",
        "Qi Sun",
        "Zemei Ge",
        "Tieming Cheng",
        "Runtao Li"
      ],
      "paper_year": 2017,
      "paper_institution": "State Key Lab of Natural and Mimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, PR China",
      "paper_cited": 12,
      "doi": "10.1016/j.ejmech.2016.12.055",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416310613-fx1_lrg.jpg",
      "compound_count": 80,
      "compound_name": "10d",
      "compound_name_drug": "",
      "compound_smiles": "c1(ccc2c(c1)c(Nc1cccc(Br)c1)ncn2)OP(=O)(N(CCCl)CCCl)NC",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 82.0,
        "selectivity": 10
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 9800.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 659.0,
        "solubility": 0.0,
        "t_half": 1.9,
        "bioavailability": 72.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 24,
      "paper_title": "Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies",
      "paper_author": [
        "Qinhuai Lai",
        "Mengdan Wu",
        "Ruixue Wang",
        "Weirong Lai",
        "Yiran Tao",
        "Ying Lu",
        "Yuxi Wang",
        "Lin Yu",
        "Ruirui Zhang",
        "Yujia Peng",
        "Xiaohua Jiang",
        "Yuyin Fu",
        "Xin Wang",
        "Zhixiong Zhang",
        "Cuiyu Guo",
        "Wei Liao",
        "Yiwen Zhang",
        "Tairan Kang",
        "Hao Chen",
        "Yuqin Yao",
        "Lantu Gou",
        "Jinliang Yang"
      ],
      "paper_year": 2020,
      "paper_institution": "State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, PR China",
      "paper_cited": 4,
      "doi": "10.1016/j.ejmech.2020.112364",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523420303342-fx1_lrg.jpg",
      "compound_count": 41,
      "compound_name": "CR55",
      "compound_name_drug": "Cryptophycin-55",
      "compound_smiles": "c1ccc(c(c1)Cl)OC",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 1.19,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 200.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 25,
      "paper_title": "Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activity",
      "paper_author": [
        "Orestis Argyros",
        "Nikolaos Lougiakis",
        "Eva Kouvari",
        "Alexandra Papafotika",
        "Catherine P. Raptopoulou",
        "Vassilis Psycharis",
        "Savvas Christoforidis",
        "Nicole Pouli",
        "Panagiotis Marakos",
        "Constantin Tamvakopoulos"
      ],
      "paper_year": 2017,
      "paper_institution": "Division of Pharmacology-Pharmacotechnology, Biomedical Research Foundation Academy of Athens (BRFAA), Athens, 11527, Greece",
      "paper_cited": 6,
      "doi": "10.1016/j.ejmech.2016.12.025",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523416310315-fx1_lrg.jpg",
      "compound_count": 37,
      "compound_name": "14a",
      "compound_name_drug": "",
      "compound_smiles": "c1cccc(Sc2cnc3c(n2)nc(c(c3)C)C)c1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 3100.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 19910.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 26,
      "paper_title": "-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor",
      "paper_author": [
        "Qianmao Liang",
        "Yongfei Chen",
        "Kailin Yu",
        "Cheng Chen",
        "Shouxiang Zhang",
        "Aoli Wang",
        "Wei Wang",
        "Hong Wu",
        "Xiaochuan Liu",
        "Beilei Wang",
        "Li Wang",
        "Zhenquan Hu",
        "Wenchao Wang",
        "Tao Ren",
        "Shanchun Zhang",
        "Qingsong Liu",
        "Cai-Hong Yun",
        "Jing Liu"
      ],
      "paper_year": 2017,
      "paper_institution": "Department of Chemistry, University of Science and Technology of China, Hefei, Anhui 230036, PR China",
      "paper_cited": 11,
      "doi": "10.1016/j.ejmech.2017.03.001",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417301502-fx1_lrg.jpg",
      "compound_count": 64,
      "compound_name": "9",
      "compound_name_drug": "",
      "compound_smiles": "c1c(NC(=O)c2ccc(C(C)(C)C)cc2)c(C)c(c2cn(c(=O)c(Nc3cc(NC(=O)C=C)c(C(=O)N4CCOCC4)cc3)c2)C)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 8.9,
        "Kd": 0.0,
        "IC50": 7.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 3000.0,
        "EC50": 30.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 181.1,
        "solubility": 0.0,
        "t_half": 0.6,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    }
  ],
  "medicinal_chemistry_similarity": [
    { "source": 0, "target": 1, "value": 0.04856895056374675 },
    { "source": 0, "target": 2, "value": 0.05285540704738761 },
    { "source": 0, "target": 3, "value": 0.04039497307001795 },
    { "source": 0, "target": 4, "value": 0.087890625 },
    { "source": 0, "target": 5, "value": 0.046840958605664486 },
    { "source": 0, "target": 6, "value": 0.053591790193842644 },
    { "source": 0, "target": 7, "value": 0.049403747870528106 },
    { "source": 0, "target": 8, "value": 0.021739130434782608 },
    { "source": 0, "target": 9, "value": 0.04934687953555878 },
    { "source": 0, "target": 10, "value": 0.05124450951683748 },
    { "source": 0, "target": 11, "value": 0.04698972099853157 },
    { "source": 0, "target": 12, "value": 0.04747774480712166 },
    { "source": 0, "target": 13, "value": 0.05673076923076923 },
    { "source": 0, "target": 14, "value": 0.048051948051948054 },
    { "source": 0, "target": 15, "value": 0.04403409090909091 },
    { "source": 0, "target": 16, "value": 0.05206655931293613 },
    { "source": 0, "target": 17, "value": 0.04785478547854786 },
    { "source": 0, "target": 18, "value": 0.04404945904173107 },
    { "source": 0, "target": 19, "value": 0.04338624338624339 },
    { "source": 0, "target": 20, "value": 0.04338624338624339 },
    { "source": 0, "target": 21, "value": 0.04338624338624339 },
    { "source": 0, "target": 22, "value": 0.09090909090909091 },
    { "source": 0, "target": 23, "value": 0.046908315565031986 },
    { "source": 0, "target": 24, "value": 0.01762114537444934 },
    { "source": 0, "target": 25, "value": 0.02860858257477243 },
    { "source": 0, "target": 26, "value": 0.05061349693251534 },
    { "source": 1, "target": 2, "value": 0.5024603608529251 },
    { "source": 1, "target": 3, "value": 0.82996632996633 },
    { "source": 1, "target": 4, "value": 0.3969816272965879 },
    { "source": 1, "target": 5, "value": 0.438136826783115 },
    { "source": 1, "target": 6, "value": 0.3083670715249663 },
    { "source": 1, "target": 7, "value": 0.4403846153846154 },
    { "source": 1, "target": 8, "value": 0.05711775043936731 },
    { "source": 1, "target": 9, "value": 0.497869750456482 },
    { "source": 1, "target": 10, "value": 0.4308231173380035 },
    { "source": 1, "target": 11, "value": 0.44780545670225386 },
    { "source": 1, "target": 12, "value": 0.35555555555555557 },
    { "source": 1, "target": 13, "value": 0.36917098445595853 },
    { "source": 1, "target": 14, "value": 0.28854314002828857 },
    { "source": 1, "target": 15, "value": 0.24643874643874644 },
    { "source": 1, "target": 16, "value": 0.5201839550332141 },
    { "source": 1, "target": 17, "value": 0.5325285043594903 },
    { "source": 1, "target": 18, "value": 0.46320346320346323 },
    { "source": 1, "target": 19, "value": 0.3566101694915254 },
    { "source": 1, "target": 20, "value": 0.3566101694915254 },
    { "source": 1, "target": 21, "value": 0.3566101694915254 },
    { "source": 1, "target": 22, "value": 0.3660949868073879 },
    { "source": 1, "target": 23, "value": 0.4143059490084986 },
    { "source": 1, "target": 24, "value": 0.0997352162400706 },
    { "source": 1, "target": 25, "value": 0.3002159827213823 },
    { "source": 1, "target": 26, "value": 0.4419588875453446 },
    { "source": 2, "target": 3, "value": 0.4791666666666667 },
    { "source": 2, "target": 4, "value": 0.4714364947310039 },
    { "source": 2, "target": 5, "value": 0.40291806958473625 },
    { "source": 2, "target": 6, "value": 0.3622787610619469 },
    { "source": 2, "target": 7, "value": 0.5175246440306681 },
    { "source": 2, "target": 8, "value": 0.05048661800486618 },
    { "source": 2, "target": 9, "value": 0.575197889182058 },
    { "source": 2, "target": 10, "value": 0.5616797900262467 },
    { "source": 2, "target": 11, "value": 0.5597054182009469 },
    { "source": 2, "target": 12, "value": 0.4251234229292375 },
    { "source": 2, "target": 13, "value": 0.4454794520547945 },
    { "source": 2, "target": 14, "value": 0.3405714285714286 },
    { "source": 2, "target": 15, "value": 0.298686464877213 },
    { "source": 2, "target": 16, "value": 0.741662518666003 },
    { "source": 2, "target": 17, "value": 0.520021645021645 },
    { "source": 2, "target": 18, "value": 0.5339702760084926 },
    { "source": 2, "target": 19, "value": 0.39118457300275483 },
    { "source": 2, "target": 20, "value": 0.39118457300275483 },
    { "source": 2, "target": 21, "value": 0.39118457300275483 },
    { "source": 2, "target": 22, "value": 0.4570466030320045 },
    { "source": 2, "target": 23, "value": 0.39667590027700833 },
    { "source": 2, "target": 24, "value": 0.08190709046454768 },
    { "source": 2, "target": 25, "value": 0.3261240751280592 },
    { "source": 2, "target": 26, "value": 0.5639784946236559 },
    { "source": 3, "target": 4, "value": 0.3641732283464567 },
    { "source": 3, "target": 5, "value": 0.43410275502606105 },
    { "source": 3, "target": 6, "value": 0.2973901098901099 },
    { "source": 3, "target": 7, "value": 0.4350097975179621 },
    { "source": 3, "target": 8, "value": 0.05974264705882353 },
    { "source": 3, "target": 9, "value": 0.49473031618102914 },
    { "source": 3, "target": 10, "value": 0.42408066429418745 },
    { "source": 3, "target": 11, "value": 0.4283154121863799 },
    { "source": 3, "target": 12, "value": 0.375 },
    { "source": 3, "target": 13, "value": 0.3341952165481577 },
    { "source": 3, "target": 14, "value": 0.2831281679942071 },
    { "source": 3, "target": 15, "value": 0.2399708242159008 },
    { "source": 3, "target": 16, "value": 0.49463464486458864 },
    { "source": 3, "target": 17, "value": 0.49899396378269617 },
    { "source": 3, "target": 18, "value": 0.4686112872542803 },
    { "source": 3, "target": 19, "value": 0.3418156808803301 },
    { "source": 3, "target": 20, "value": 0.3418156808803301 },
    { "source": 3, "target": 21, "value": 0.3418156808803301 },
    { "source": 3, "target": 22, "value": 0.33487450462351387 },
    { "source": 3, "target": 23, "value": 0.41909620991253643 },
    { "source": 3, "target": 24, "value": 0.10230414746543778 },
    { "source": 3, "target": 25, "value": 0.2997779422649889 },
    { "source": 3, "target": 26, "value": 0.42638973732437385 },
    { "source": 4, "target": 5, "value": 0.3503230437903805 },
    { "source": 4, "target": 6, "value": 0.29403508771929826 },
    { "source": 4, "target": 7, "value": 0.41392904073587383 },
    { "source": 4, "target": 8, "value": 0.07156673114119923 },
    { "source": 4, "target": 9, "value": 0.42788171394085694 },
    { "source": 4, "target": 10, "value": 0.4065671641791045 },
    { "source": 4, "target": 11, "value": 0.40059701492537314 },
    { "source": 4, "target": 12, "value": 0.3299731182795699 },
    { "source": 4, "target": 13, "value": 0.34242021276595747 },
    { "source": 4, "target": 14, "value": 0.2652014652014652 },
    { "source": 4, "target": 15, "value": 0.2509448223733938 },
    { "source": 4, "target": 16, "value": 0.5102254850550603 },
    { "source": 4, "target": 17, "value": 0.3922441195168468 },
    { "source": 4, "target": 18, "value": 0.3847560975609756 },
    { "source": 4, "target": 19, "value": 0.33660589060308554 },
    { "source": 4, "target": 20, "value": 0.33660589060308554 },
    { "source": 4, "target": 21, "value": 0.33660589060308554 },
    { "source": 4, "target": 22, "value": 0.6303630363036303 },
    { "source": 4, "target": 23, "value": 0.3403805496828753 },
    { "source": 4, "target": 24, "value": 0.07169459962756052 },
    { "source": 4, "target": 25, "value": 0.29425113464447805 },
    { "source": 4, "target": 26, "value": 0.39209726443769 },
    { "source": 5, "target": 6, "value": 0.2967791411042945 },
    { "source": 5, "target": 7, "value": 0.4601899196493791 },
    { "source": 5, "target": 8, "value": 0.0670391061452514 },
    { "source": 5, "target": 9, "value": 0.41315453384418904 },
    { "source": 5, "target": 10, "value": 0.3734413965087282 },
    { "source": 5, "target": 11, "value": 0.37924528301886795 },
    { "source": 5, "target": 12, "value": 0.328 },
    { "source": 5, "target": 13, "value": 0.29403606102635227 },
    { "source": 5, "target": 14, "value": 0.27037933817594834 },
    { "source": 5, "target": 15, "value": 0.2413223140495868 },
    { "source": 5, "target": 16, "value": 0.4158878504672897 },
    { "source": 5, "target": 17, "value": 0.42248603351955305 },
    { "source": 5, "target": 18, "value": 0.42434431741761935 },
    { "source": 5, "target": 19, "value": 0.3381679389312977 },
    { "source": 5, "target": 20, "value": 0.3381679389312977 },
    { "source": 5, "target": 21, "value": 0.3381679389312977 },
    { "source": 5, "target": 22, "value": 0.2984330484330484 },
    { "source": 5, "target": 23, "value": 0.5714285714285714 },
    { "source": 5, "target": 24, "value": 0.09790979097909791 },
    { "source": 5, "target": 25, "value": 0.27704918032786885 },
    { "source": 5, "target": 26, "value": 0.35253164556962024 },
    { "source": 6, "target": 7, "value": 0.31501340482573725 },
    { "source": 6, "target": 8, "value": 0.0863905325443787 },
    { "source": 6, "target": 9, "value": 0.34155363748458695 },
    { "source": 6, "target": 10, "value": 0.3545966228893058 },
    { "source": 6, "target": 11, "value": 0.35512256442489 },
    { "source": 6, "target": 12, "value": 0.303935860058309 },
    { "source": 6, "target": 13, "value": 0.30642857142857144 },
    { "source": 6, "target": 14, "value": 0.21598101265822786 },
    { "source": 6, "target": 15, "value": 0.24680851063829787 },
    { "source": 6, "target": 16, "value": 0.3844570252187339 },
    { "source": 6, "target": 17, "value": 0.31926121372031663 },
    { "source": 6, "target": 18, "value": 0.3331197950032031 },
    { "source": 6, "target": 19, "value": 0.274888558692422 },
    { "source": 6, "target": 20, "value": 0.274888558692422 },
    { "source": 6, "target": 21, "value": 0.274888558692422 },
    { "source": 6, "target": 22, "value": 0.2793696275071633 },
    { "source": 6, "target": 23, "value": 0.2766592095451156 },
    { "source": 6, "target": 24, "value": 0.06896551724137931 },
    { "source": 6, "target": 25, "value": 0.22760290556900725 },
    { "source": 6, "target": 26, "value": 0.32075471698113206 },
    { "source": 7, "target": 8, "value": 0.057808455565142365 },
    { "source": 7, "target": 9, "value": 0.4954846478025286 },
    { "source": 7, "target": 10, "value": 0.44678362573099417 },
    { "source": 7, "target": 11, "value": 0.47368421052631576 },
    { "source": 7, "target": 12, "value": 0.38507265521796563 },
    { "source": 7, "target": 13, "value": 0.3804909560723514 },
    { "source": 7, "target": 14, "value": 0.3020465772759351 },
    { "source": 7, "target": 15, "value": 0.2673338098641887 },
    { "source": 7, "target": 16, "value": 0.5303726391015824 },
    { "source": 7, "target": 17, "value": 0.47664747280870123 },
    { "source": 7, "target": 18, "value": 0.4912609238451935 },
    { "source": 7, "target": 19, "value": 0.3602150537634409 },
    { "source": 7, "target": 20, "value": 0.3602150537634409 },
    { "source": 7, "target": 21, "value": 0.3602150537634409 },
    { "source": 7, "target": 22, "value": 0.3677335075114304 },
    { "source": 7, "target": 23, "value": 0.4086471408647141 },
    { "source": 7, "target": 24, "value": 0.11806167400881057 },
    { "source": 7, "target": 25, "value": 0.28893587033121915 },
    { "source": 7, "target": 26, "value": 0.4427801078490114 },
    { "source": 8, "target": 9, "value": 0.053401609363569864 },
    { "source": 8, "target": 10, "value": 0.06319702602230483 },
    { "source": 8, "target": 11, "value": 0.06847253574115876 },
    { "source": 8, "target": 12, "value": 0.0755873340143003 },
    { "source": 8, "target": 13, "value": 0.06634146341463415 },
    { "source": 8, "target": 14, "value": 0.05952380952380952 },
    { "source": 8, "target": 15, "value": 0.06578947368421052 },
    { "source": 8, "target": 16, "value": 0.048845947396672036 },
    { "source": 8, "target": 17, "value": 0.06040268456375839 },
    { "source": 8, "target": 18, "value": 0.05572998430141287 },
    { "source": 8, "target": 19, "value": 0.053763440860215055 },
    { "source": 8, "target": 20, "value": 0.053763440860215055 },
    { "source": 8, "target": 21, "value": 0.053763440860215055 },
    { "source": 8, "target": 22, "value": 0.07802874743326489 },
    { "source": 8, "target": 23, "value": 0.05059203444564048 },
    { "source": 8, "target": 24, "value": 0.07655502392344497 },
    { "source": 8, "target": 25, "value": 0.05510752688172043 },
    { "source": 8, "target": 26, "value": 0.06479313036690086 },
    { "source": 9, "target": 10, "value": 0.5143661971830986 },
    { "source": 9, "target": 11, "value": 0.49776286353467564 },
    { "source": 9, "target": 12, "value": 0.37970149253731345 },
    { "source": 9, "target": 13, "value": 0.40107270560190705 },
    { "source": 9, "target": 14, "value": 0.29905362776025235 },
    { "source": 9, "target": 15, "value": 0.2902597402597403 },
    { "source": 9, "target": 16, "value": 0.6230419403739262 },
    { "source": 9, "target": 17, "value": 0.4835294117647059 },
    { "source": 9, "target": 18, "value": 0.4985607369027058 },
    { "source": 9, "target": 19, "value": 0.3823347745521927 },
    { "source": 9, "target": 20, "value": 0.3823347745521927 },
    { "source": 9, "target": 21, "value": 0.3823347745521927 },
    { "source": 9, "target": 22, "value": 0.3795576808129109 },
    { "source": 9, "target": 23, "value": 0.4166138237159163 },
    { "source": 9, "target": 24, "value": 0.06767458603311735 },
    { "source": 9, "target": 25, "value": 0.32748538011695905 },
    { "source": 9, "target": 26, "value": 0.505166475315729 },
    { "source": 10, "target": 11, "value": 0.49971894322653176 },
    { "source": 10, "target": 12, "value": 0.3894927536231884 },
    { "source": 10, "target": 13, "value": 0.4110910186859554 },
    { "source": 10, "target": 14, "value": 0.345370978332239 },
    { "source": 10, "target": 15, "value": 0.2829331602855289 },
    { "source": 10, "target": 16, "value": 0.607429718875502 },
    { "source": 10, "target": 17, "value": 0.5059952038369304 },
    { "source": 10, "target": 18, "value": 0.5058072009291521 },
    { "source": 10, "target": 19, "value": 0.37276648182378314 },
    { "source": 10, "target": 20, "value": 0.37276648182378314 },
    { "source": 10, "target": 21, "value": 0.37276648182378314 },
    { "source": 10, "target": 22, "value": 0.37604790419161677 },
    { "source": 10, "target": 23, "value": 0.36107711138310894 },
    { "source": 10, "target": 24, "value": 0.06430635838150289 },
    { "source": 10, "target": 25, "value": 0.2949044585987261 },
    { "source": 10, "target": 26, "value": 0.5239206534422404 },
    { "source": 11, "target": 12, "value": 0.43997485857950974 },
    { "source": 11, "target": 13, "value": 0.39413875598086123 },
    { "source": 11, "target": 14, "value": 0.30287539936102237 },
    { "source": 11, "target": 15, "value": 0.26739690721649484 },
    { "source": 11, "target": 16, "value": 0.6137512639029322 },
    { "source": 11, "target": 17, "value": 0.4631578947368421 },
    { "source": 11, "target": 18, "value": 0.4634560906515581 },
    { "source": 11, "target": 19, "value": 0.36660505237215035 },
    { "source": 11, "target": 20, "value": 0.36660505237215035 },
    { "source": 11, "target": 21, "value": 0.36660505237215035 },
    { "source": 11, "target": 22, "value": 0.3841500302480339 },
    { "source": 11, "target": 23, "value": 0.36666666666666664 },
    { "source": 11, "target": 24, "value": 0.07811348563006633 },
    { "source": 11, "target": 25, "value": 0.29182630906768836 },
    { "source": 11, "target": 26, "value": 0.5031773541305604 },
    { "source": 12, "target": 13, "value": 0.32345013477088946 },
    { "source": 12, "target": 14, "value": 0.2831926323867997 },
    { "source": 12, "target": 15, "value": 0.2374323279195669 },
    { "source": 12, "target": 16, "value": 0.4531893004115226 },
    { "source": 12, "target": 17, "value": 0.36683738796414855 },
    { "source": 12, "target": 18, "value": 0.38847117794486213 },
    { "source": 12, "target": 19, "value": 0.29350104821802936 },
    { "source": 12, "target": 20, "value": 0.29350104821802936 },
    { "source": 12, "target": 21, "value": 0.29350104821802936 },
    { "source": 12, "target": 22, "value": 0.32300275482093666 },
    { "source": 12, "target": 23, "value": 0.29796205200281095 },
    { "source": 12, "target": 24, "value": 0.09272183449651047 },
    { "source": 12, "target": 25, "value": 0.24417731029301276 },
    { "source": 12, "target": 26, "value": 0.3762315270935961 },
    { "source": 13, "target": 14, "value": 0.2728624535315985 },
    { "source": 13, "target": 15, "value": 0.3632585203657523 },
    { "source": 13, "target": 16, "value": 0.4722507708119219 },
    { "source": 13, "target": 17, "value": 0.402321083172147 },
    { "source": 13, "target": 18, "value": 0.3798165137614679 },
    { "source": 13, "target": 19, "value": 0.330752990851513 },
    { "source": 13, "target": 20, "value": 0.330752990851513 },
    { "source": 13, "target": 21, "value": 0.330752990851513 },
    { "source": 13, "target": 22, "value": 0.3276912660798917 },
    { "source": 13, "target": 23, "value": 0.29069767441860467 },
    { "source": 13, "target": 24, "value": 0.07473982970671712 },
    { "source": 13, "target": 25, "value": 0.26096654275092934 },
    { "source": 13, "target": 26, "value": 0.4069264069264069 },
    { "source": 14, "target": 15, "value": 0.20680393912264997 },
    { "source": 14, "target": 16, "value": 0.33454356846473027 },
    { "source": 14, "target": 17, "value": 0.3121951219512195 },
    { "source": 14, "target": 18, "value": 0.30498338870431896 },
    { "source": 14, "target": 19, "value": 0.2610410094637224 },
    { "source": 14, "target": 20, "value": 0.2610410094637224 },
    { "source": 14, "target": 21, "value": 0.2610410094637224 },
    { "source": 14, "target": 22, "value": 0.2558314522197141 },
    { "source": 14, "target": 23, "value": 0.25887924230465664 },
    { "source": 14, "target": 24, "value": 0.12383488681757657 },
    { "source": 14, "target": 25, "value": 0.22193211488250653 },
    { "source": 14, "target": 26, "value": 0.3326612903225806 },
    { "source": 15, "target": 16, "value": 0.3087388801674516 },
    { "source": 15, "target": 17, "value": 0.2602644398051496 },
    { "source": 15, "target": 18, "value": 0.26639892904953144 },
    { "source": 15, "target": 19, "value": 0.2526661197703035 },
    { "source": 15, "target": 20, "value": 0.2526661197703035 },
    { "source": 15, "target": 21, "value": 0.2526661197703035 },
    { "source": 15, "target": 22, "value": 0.22469325153374234 },
    { "source": 15, "target": 23, "value": 0.23519870235198703 },
    { "source": 15, "target": 24, "value": 0.061898211829436035 },
    { "source": 15, "target": 25, "value": 0.2231404958677686 },
    { "source": 15, "target": 26, "value": 0.26556291390728476 },
    { "source": 16, "target": 17, "value": 0.5418994413407822 },
    { "source": 16, "target": 18, "value": 0.5878757004584819 },
    { "source": 16, "target": 19, "value": 0.42590673575129534 },
    { "source": 16, "target": 20, "value": 0.42590673575129534 },
    { "source": 16, "target": 21, "value": 0.42590673575129534 },
    { "source": 16, "target": 22, "value": 0.46979166666666666 },
    { "source": 16, "target": 23, "value": 0.42531120331950206 },
    { "source": 16, "target": 24, "value": 0.06336528221512247 },
    { "source": 16, "target": 25, "value": 0.3262448132780083 },
    { "source": 16, "target": 26, "value": 0.6 },
    { "source": 17, "target": 18, "value": 0.5178236397748592 },
    { "source": 17, "target": 19, "value": 0.35390676296782664 },
    { "source": 17, "target": 20, "value": 0.35390676296782664 },
    { "source": 17, "target": 21, "value": 0.35390676296782664 },
    { "source": 17, "target": 22, "value": 0.36754329698524696 },
    { "source": 17, "target": 23, "value": 0.41735537190082644 },
    { "source": 17, "target": 24, "value": 0.09372384937238494 },
    { "source": 17, "target": 25, "value": 0.2858126721763085 },
    { "source": 17, "target": 26, "value": 0.4594272076372315 },
    { "source": 18, "target": 19, "value": 0.3623649078194533 },
    { "source": 18, "target": 20, "value": 0.3623649078194533 },
    { "source": 18, "target": 21, "value": 0.3623649078194533 },
    { "source": 18, "target": 22, "value": 0.3685837971552257 },
    { "source": 18, "target": 23, "value": 0.42220744680851063 },
    { "source": 18, "target": 24, "value": 0.10685805422647528 },
    { "source": 18, "target": 25, "value": 0.29953302201467646 },
    { "source": 18, "target": 26, "value": 0.4481375358166189 },
    { "source": 19, "target": 20, "value": 1.0 },
    { "source": 19, "target": 21, "value": 1.0 },
    { "source": 19, "target": 22, "value": 0.2968421052631579 },
    { "source": 19, "target": 23, "value": 0.3179791976225854 },
    { "source": 19, "target": 24, "value": 0.07345225603357818 },
    { "source": 19, "target": 25, "value": 0.2890879478827362 },
    { "source": 19, "target": 26, "value": 0.3520950594121326 },
    { "source": 20, "target": 21, "value": 1.0 },
    { "source": 20, "target": 22, "value": 0.2968421052631579 },
    { "source": 20, "target": 23, "value": 0.3179791976225854 },
    { "source": 20, "target": 24, "value": 0.07345225603357818 },
    { "source": 20, "target": 25, "value": 0.2890879478827362 },
    { "source": 20, "target": 26, "value": 0.3520950594121326 },
    { "source": 21, "target": 22, "value": 0.2968421052631579 },
    { "source": 21, "target": 23, "value": 0.3179791976225854 },
    { "source": 21, "target": 24, "value": 0.07345225603357818 },
    { "source": 21, "target": 25, "value": 0.2890879478827362 },
    { "source": 21, "target": 26, "value": 0.3520950594121326 },
    { "source": 22, "target": 23, "value": 0.29859154929577464 },
    { "source": 22, "target": 24, "value": 0.07262021589793916 },
    { "source": 22, "target": 25, "value": 0.24379232505643342 },
    { "source": 22, "target": 26, "value": 0.3803339517625232 },
    { "source": 23, "target": 24, "value": 0.08983957219251337 },
    { "source": 23, "target": 25, "value": 0.26623897353648757 },
    { "source": 23, "target": 26, "value": 0.3529780564263323 },
    { "source": 24, "target": 25, "value": 0.07253886010362694 },
    { "source": 24, "target": 26, "value": 0.06914893617021277 },
    { "source": 25, "target": 26, "value": 0.29152987524622453 }
  ],
  "metrics_paper_count": {
    "IC50_MC": 23,
    "Ki_MC": 1,
    "Kd_MC": 3,
    "Selectivity_MC": 3,
    "IC50_Ph": 22,
    "Ki_Ph": 0,
    "Kd_Ph": 0,
    "EC50_Ph": 2,
    "Selectivity_Ph": 0,
    "hERG_Ph": 0,
    "solubility_Ph": 0,
    "ED50_Cl": 1,
    "thalf_Cl": 5,
    "AUC_Cl": 7,
    "bio_Cl": 4,
    "solubility_Cl": 0,
    "adverse_1": 76,
    "adverse_2": 57,
    "adverse_3": 10
  },
  "metrics_distribution": {
    "IC50_MC": [
      12.0, 17.0, 0.16, 0.98, 15.7, 4.1, 9.0, 14.0, 32.0, 48.0, 2.1, 600.0,
      800.0, 422.3, 91.7, 752.0, 390.0, 390.0, 390.0, 73.0, 82.0, 1.19, 7.0
    ],
    "Ki_MC": [8.9],
    "Kd_MC": [4.9, 4.5, 7.8],
    "Selectivity_MC": [100, 38, 10],
    "IC50_Ph": [
      205.0, 11.0, 600.0, 32.0, 2000.0, 200.0, 310.0, 0.203, 75000.0, 958.0,
      250.0, 4.8, 4830.0, 68000.0, 120.0, 120.0, 120.0, 4220.0, 9800.0, 200.0,
      3100.0, 3000.0
    ],
    "Ki_Ph": [],
    "Kd_Ph": [],
    "EC50_Ph": [3.8, 30.0],
    "Selectivity_Ph": [],
    "hERG_Ph": [],
    "solubility_Ph": [],
    "ED50_Cl": [100.0],
    "thalf_Cl": [2.42, 72.0, 2.3, 1.9, 0.6],
    "AUC_Cl": [5.63, 0.9, 147.0, 1520.0, 659.0, 19910.0, 181.1],
    "bio_Cl": [100.2, 83.0, 41.5, 72.0],
    "solubility_Cl": [],
    "adverse_1": [],
    "adverse_2": [
      0.10135135135135136, 0.0784313725490196, 1.0, 0.1, 0.4666666666666667,
      0.44
    ],
    "adverse_3": [0.2531017369727047]
  }
}
